The Morphine Market Size was valued at USD 24.48 billion in 2022 and is expected to reach USD 45.31 billion by 2030 and grow at a CAGR of 8% over the forecast period 2023-2030.
Morphine is an analgesic and narcotic medication derived from opium that is used to treat moderate to severe pain. According to the International Narcotics Control Board, 17 percent of the world's population consumes 92% of the world's morphine, while the rest of the world population consumes roughly 8%. The market for is being driven by reasons such as lifestyle changes that cause pain and an increase in the number of surgical operations as the drug is recommended for pain management post-surgery. However, the drug's addictive nature limits the global morphine market's expansion.
Get more information on Morphine Market - Request Sample Report
Because morphine is one of the most powerful pain medications, the increased use of morphine for pain treatment is a crucial factor contributing to market growth. Furthermore, the increasing rate of government legalisation of strong opioids for medicinal use in several emerging nations is likely to generate considerable potential for company expansion for existing players while facilitating easy entry for new players into the global morphine market.
KEY DRIVERS:
The global prevalence of orthopaedic diseases is increasing.
Morphine demand is increasing as the cancer population grows.
RESTRAINTS:
The addictive nature of the medicine limits the worldwide morphine market's expansion.
Strict government regulations and morphine-related negative effects.
Chronic pain management is difficult during the COVID-19 pandemic, owing to changes in the healthcare delivery system caused by safety concerns and social isolation. Chronic pain, on the other hand, is a big issue that affects 13.5 percent to 47% of the general population and can impose a significant financial burden. Furthermore, elective surgeries and consultations were cancelled; nearly 88 percent of cancer care centres faced challenges in providing standard cancer care due to a lack of personal protective equipment and a staff shortage, which impacted hospitals and pain clinics, ultimately affecting the morphine market.
More than 95% of morphine originates in Afghanistan, Mexico, and Myanmar, according to the supply chain. Opium poppy is produced in fields in all three countries, and harvesting opium is a labor-intensive job. However, the COVID-19 problem impedes opium production in various ways, including reduced worker availability, restricted trade due to rigorous border controls, and laboratories encountering chemical shortages due to lockdown measures. As a result, restricting cross-border imports and exports may cause supply chain disruptions, leading in considerable losses for morphine suppliers.
Injection Morphine is administered by injection into a vein, a muscle, or under the skin to patients who are vomiting, unconscious, or in an emergency.
Oral Due to the increasing prescription and capability of morphine as strong pain medications among pharmacists worldwide, the oral segment is predicted to rise rapidly in the global morphine market.
Management of Pain Morphine is a pain medication prescribed for moderate to severe pain. Extended-release morphine pills and capsules are only used to treat severe pain that has not been controlled by other pain medicines. Furthermore, opioids are critical in providing sufficient analgesia in acute post-operative conditions.
According to the International Osteoporosis Foundation, osteoporosis is one of the most serious public health crises affecting women, affecting more than 30% of the population in the United States and Europe each year and causing numerous fractures. According to research, the increasing prevalence of pain-related diseases drives sector growth. Cancer pain, neuropathic pain, osteoarthritis pain, and other pain management are sub-segments of the pain management segment.
Diarrhea Treatment Diarrhea is a common and potentially fatal complication in cancer patients. A local infection, systemic inflammation, or a side effect of radiotherapy or chemotherapy could all be to blame. Morphine works on mu-receptors in the colon, delaying transit time and increasing net absorption.
The European Society for Medical Oncology has demonstrated the role of opium-like morphine tincture (10 mg/mL morphine) in the treatment of diarrhoea (ESMO)
Cold and cough reliever Cough affects approximately 65% of lung cancer patients and 70% of COPD patients. Morphine sulphate is an effective antitussive in the treatment of persistent cough.
Clinics and hospitals The global expansion of hospital infrastructure is propelling the morphine market. Morphine demand in hospitals and clinics increases as the number of orthopaedic problems and cancer patients increases. Hospitals and clinics held the majority share in 2021 because to the significant number of orthopaedic surgeries and cancer therapy performed in hospitals and clinics as the incidence of cancer and orthopaedic problems increased.
In the United Kingdom, more than 10 million people suffer from arthritis or other joint-related ailments. Ambulatory Surgical Facilities: Outpatient services can include a variety of procedures such as surgeries, minimally invasive therapies, and others. Furthermore, ambulatory surgery centres are designed to maximise the efficiency of health care delivery, propelling the morphine market sector forward.
Pharmacies in Hospitals In 2021, the hospital pharmacy segment retained a sizable market share. Because most hospitals have in-house pharmacies, the need for a prescription for chemotherapy-related pain and other types of chronic pain in orthopaedic conditions such as arthritis, fibromyalgia, osteoporosis, and elbow discomfort strengthens the hospital pharmacy business.
Online Shops Because online stores are easy, time-saving, and cost-effective, they are predicted to be the fastest-growing segment during the forecast period.
Pharmacy Chains A retail pharmacy is an independent pharmacy, a supermarket pharmacy, a chain pharmacy, or a mass merchandiser pharmacy that has a state licence to distribute pharmaceuticals to the general public at retail prices. The expansion of the retail pharmacies category can be attributed to the ease of access to these distribution channels, particularly in rural areas and tier-II cities in developing and underdeveloped economies.
VALUE CHAIN ANALYSIS:
The global morphine market is expanding gradually and is likely to continue doing so in the near future. This is attributable to an increase in the use of morphine for pain management, improved morphine regulations, established healthcare infrastructure, and the availability of better medical facilities, as well as an increase in the patient pool with cancer, orthopaedic disorders, and other chronic diseases. The global morphine market value chain study includes five important components: raw material procurement, R&D, product manufacturing, distribution and sales, and post-sales monitoring.
by End User
Hospitals& Clinics
by Dosage Form
Injection
Oral
by Application
Pain Management
Diarrhea Suppressant
Cold &Cough Suppressant
by Distribution Channel
Hospital Pharmacies
Retail Pharmacies
.png)
Need any customization research on Morphine Market - Enquiry Now
The Asia-Pacific morphine market is expected to be the fastest expanding in the region. The increased frequency of chronic diseases such as cardiovascular problems, as well as an increasing patient population and innovative treatment options, are the primary drivers of market expansion. Furthermore, increased healthcare expenditure in the region is propelling the Asia Pacific morphine market forward.
The morphine market is highly consolidated, with a number of major players engaged in this field. They primarily do research and development for pain management and other therapeutic applications such as cough and diarrhoea suppression in a variety of clinical and research settings.
Furthermore, market participants are offering mergers and acquisitions, contractual agreements, new product launches, increased investments, and collaboration with other companies in order to grow their global presence.
REGIONAL COVERAGE:
North America
USA
Canada
Mexico
Europe
Germany
UK
France
Italy
Spain
The Netherlands
Rest of Europe
Asia-Pacific
Japan
south Korea
China
India
Australia
Rest of Asia-Pacific
The Middle East & Africa
Israel
UAE
South Africa
Rest of Middle East & Africa
Latin America
Brazil
Argentina
Rest of Latin America
Major players are Mallinckrodt Pharmaceuticals, Sanofi Winthrop Industrie, Macfarlan Smith, Northeast Pharmaceutical Group, Pfizer Inc., Verve Health Care Ltd., Alcaliber, Purdue Pharma, Sun Pharmaceutical Industries, Qinghai Pharmaceutical and Other Players.
| Report Attributes | Details |
|---|---|
| Market Size in 2022 | US$ 24.48 Billion |
| Market Size by 2030 | US$ 45.31 Billion |
| CAGR | CAGR of 8% From 2023 to 2030 |
| Base Year | 2022 |
| Forecast Period | 2023-2030 |
| Historical Data | 2020-2021 |
| Report Scope & Coverage | Market Size, Segments Analysis, Competitive Landscape, Regional Analysis, DROC & SWOT Analysis, Forecast Outlook |
| Key Segments | • by End User (Hospitals& Clinics, Ambulatory Surgical Centers) • by Dosage Form (Injection, Oral) • by Application (Pain Management, Diarrhea Suppressant, Cold &Cough Suppressant) • by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) |
| Regional Analysis/Coverage | North America (USA, Canada, Mexico), Europe (Germany, UK, France, Italy, Spain, Netherlands, Rest of Europe), Asia-Pacific (Japan, South Korea, China, India, Australia, Rest of Asia-Pacific), The Middle East & Africa (Israel, UAE, South Africa, Rest of Middle East & Africa), Latin America (Brazil, Argentina, Rest of Latin America) |
| Company Profiles | Mallinckrodt Pharmaceuticals, Sanofi Winthrop Industrie, Macfarlan Smith, Northeast Pharmaceutical Group, Pfizer Inc., Verve Health Care Ltd., Alcaliber, Purdue Pharma, Sun Pharmaceutical Industries, Qinghai Pharmaceutical. |
| Key Drivers | • The global prevalence of orthopaedic diseases is increasing. • Morphine demand is increasing as the cancer population grows. |
| RESTRAINTS | • The addictive nature of the medicine limits the worldwide morphine market's expansion. • Strict government regulations and morphine-related negative effects |
Ans: The Morphine market is expected to reach USD 45.31 billion by 2030.
Ans: The Morphine market is grown at a CAGR of 8 % From 2023 to 2030.
Ans: The forecast period of the Morphine Market is 2023-2030.
Ans: The major players are Mallinckrodt Pharmaceuticals, Sanofi Winthrop Industrie, Macfarlan Smith, Northeast Pharmaceutical Group, Pfizer Inc., Verve Health Care Ltd., Alcaliber, Purdue Pharma, Sun Pharmaceutical Industries, Qinghai Pharmaceutical., and others in the final report.
The global prevalence of orthopedic diseases is increasing.
Morphine demand is increasing as the cancer population grows.
Table of Contents
1. Introduction
1.1 Market Definition
1.2 Scope
1.3 Research Assumptions
2. Research Methodology
3. Market Dynamics
3.1 Drivers
3.2 Restraints
3.3 Opportunities
3.4 Challenges
4. Impact Analysis
4.1 COVID-19 Impact Analysis
4.2 Impact of Ukraine- Russia war
4.3 Impact of ongoing Recession
4.3.1 Introduction
4.3.2 Impact on major economies
4.3.2.1 US
4.3.2.2 Canada
4.3.2.3 Germany
4.3.2.4 France
4.3.2.5 United Kingdom
4.3.2.6 China
4.3.2.7 Japan
4.3.2.8 South Korea
4.3.2.9 Rest of the World
5. Value Chain Analysis
6. Porter’s 5 forces model
7. PEST Analysis
8. Morphine Market, by End User
8.1 Hospitals& Clinics
8.2 Ambulatory Surgical Centers
9. Morphine Market, by Dosage Form
9.1 Injection
9.2 Oral
10. Morphine Market, by Application
10.1 Pain Management
10.2 Diarrhea Suppressant
10.3 Cold &Cough Suppressant
11. Morphine Market, by Distribution Channel
11.1 Hospital Pharmacies
11.2 Retail Pharmacies
11.3 Online Pharmacies
12. Regional Analysis
12.1 Introduction
12.2 North America
12.2.1 USA
12.2.2 Canada
12.2.3 Mexico
12.3 Europe
12.3.1 Germany
12.3.2 UK
12.3.3 France
12.3.4 Italy
12.3.5 Spain
12.3.6 The Netherlands
12.3.7 Rest of Europe
12.4 Asia-Pacific
12.4.1 Japan
12.4.2 South Korea
12.4.3 China
12.4.4 India
12.4.5 Australia
12.4.6 Rest of Asia-Pacific
12.5 The Middle East & Africa
12.5.1 Israel
12.5.2 UAE
12.5.3 South Africa
12.5.4 Rest
12.6 Latin America
12.6.1 Brazil
12.6.2 Argentina
12.6.3 Rest of Latin America
13. Company Profiles
13.1 Mallinckrodt Pharmaceuticals
13.1.1 Financial
13.1.2 Products/ Services Offered
13.1.3 SWOT Analysis
13.1.4 The SNS view
13.2 Sanofi Winthrop Industrie
13.3 Macfarlan Smith
13.4 Northeast Pharmaceutical Group
13.5 Pfizer Inc.
13.6 Verve Health Care Ltd.
13.7 Alcaliber
13.8 Purdue Pharma
13.9 Sun Pharmaceutical Industries
13.10 Qinghai Pharmaceutical
14. Competitive Landscape
14.1 Competitive Benchmarking
14.2 Market Share Analysis
14.3 Recent Developments
15. Conclusion
An accurate research report requires proper strategizing as well as implementation. There are multiple factors involved in the completion of good and accurate research report and selecting the best methodology to compete the research is the toughest part. Since the research reports we provide play a crucial role in any company’s decision-making process, therefore we at SNS Insider always believe that we should choose the best method which gives us results closer to reality. This allows us to reach at a stage wherein we can provide our clients best and accurate investment to output ratio.
Each report that we prepare takes a timeframe of 350-400 business hours for production. Starting from the selection of titles through a couple of in-depth brain storming session to the final QC process before uploading our titles on our website we dedicate around 350 working hours. The titles are selected based on their current market cap and the foreseen CAGR and growth.
The 5 steps process:
Step 1: Secondary Research:
Secondary Research or Desk Research is as the name suggests is a research process wherein, we collect data through the readily available information. In this process we use various paid and unpaid databases which our team has access to and gather data through the same. This includes examining of listed companies’ annual reports, Journals, SEC filling etc. Apart from this our team has access to various associations across the globe across different industries. Lastly, we have exchange relationships with various university as well as individual libraries.
Step 2: Primary Research
When we talk about primary research, it is a type of study in which the researchers collect relevant data samples directly, rather than relying on previously collected data. This type of research is focused on gaining content specific facts that can be sued to solve specific problems. Since the collected data is fresh and first hand therefore it makes the study more accurate and genuine.
We at SNS Insider have divided Primary Research into 2 parts.
Part 1 wherein we interview the KOLs of major players as well as the upcoming ones across various geographic regions. This allows us to have their view over the market scenario and acts as an important tool to come closer to the accurate market numbers. As many as 45 paid and unpaid primary interviews are taken from both the demand and supply side of the industry to make sure we land at an accurate judgement and analysis of the market.
This step involves the triangulation of data wherein our team analyses the interview transcripts, online survey responses and observation of on filed participants. The below mentioned chart should give a better understanding of the part 1 of the primary interview.
Part 2: In this part of primary research the data collected via secondary research and the part 1 of the primary research is validated with the interviews from individual consultants and subject matter experts.
Consultants are those set of people who have at least 12 years of experience and expertise within the industry whereas Subject Matter Experts are those with at least 15 years of experience behind their back within the same space. The data with the help of two main processes i.e., FGDs (Focused Group Discussions) and IDs (Individual Discussions). This gives us a 3rd party nonbiased primary view of the market scenario making it a more dependable one while collation of the data pointers.
Step 3: Data Bank Validation
Once all the information is collected via primary and secondary sources, we run that information for data validation. At our intelligence centre our research heads track a lot of information related to the market which includes the quarterly reports, the daily stock prices, and other relevant information. Our data bank server gets updated every fortnight and that is how the information which we collected using our primary and secondary information is revalidated in real time.
Step 4: QA/QC Process
After all the data collection and validation our team does a final level of quality check and quality assurance to get rid of any unwanted or undesired mistakes. This might include but not limited to getting rid of the any typos, duplication of numbers or missing of any important information. The people involved in this process include technical content writers, research heads and graphics people. Once this process is completed the title gets uploader on our platform for our clients to read it.
Step 5: Final QC/QA Process:
This is the last process and comes when the client has ordered the study. In this process a final QA/QC is done before the study is emailed to the client. Since we believe in giving our clients a good experience of our research studies, therefore, to make sure that we do not lack at our end in any way humanly possible we do a final round of quality check and then dispatch the study to the client.
Leukemia Therapeutics Market size was USD 8275.45 Million in 2022 and is expected to Reach USD 13491.42 Million by 2030 and grow at a CAGR of 6.3 % over the forecast period of 2023-2030.
The Diabetes Devices Market size was estimated USD 29.1 billion in 2022 and is expected to reach USD 53.06 billion By 2030 at a CAGR of 7.8% during the forecast period of 2023-2030.
The Medical Collagen Market Size was valued at USD 6.71 billion in 2022, and is expected to reach USD 11.02 billion by 2030, and grow at a CAGR of 6.4% over the forecast period 2023-2030.
The Medical Swabs Market size was valued at USD 2.95 billion in 2022 and is expected to reach at USD 5.01 billion by 2030, and grow at a CAGR of 6.8% over the forecast period of 2023-2030
The Computerized Physician Order Entry Market Size was valued at USD 1.70 billion in 2022, and expected to reach USD 2.86 billion by 2030, and grow at a CAGR of 6.7% over the forecast period 2023-2030.
The Oxygen Flow Meters Market Size was valued at USD 1.18 billion in 2022 and is expected to reach USD 1.87 billion by 2030, and grow at a CAGR of 5.9% over the forecast period 2023-2030.
Hi! Click one of our member below to chat on Phone
© 2024 All Rights Reserved by SNS Insider Pvt Ltd
